
### [MONDO:0017169](http://purl.obolibrary.org/obo/MONDO_0017169)
**Label:** multiple endocrine neoplasia

**Subclasses:** [MONDO:0012552](http://purl.obolibrary.org/obo/MONDO_0012552) (multiple endocrine neoplasia type 4), [MONDO:0019003](http://purl.obolibrary.org/obo/MONDO_0019003) (multiple endocrine neoplasia type 2), [MONDO:0007540](http://purl.obolibrary.org/obo/MONDO_0007540) (multiple endocrine neoplasia type 1), [MONDO:0007958](http://purl.obolibrary.org/obo/MONDO_0007958) (familial medullary thyroid carcinoma), [MONDO:0008082](http://purl.obolibrary.org/obo/MONDO_0008082) (multiple endocrine neoplasia type 2B), 

**Corr. equiv. classes:** [OMIM:162300](http://purl.obolibrary.org/obo/OMIM_162300), [Orphanet:652](http://www.orpha.net/ORDO/Orphanet_652), [Orphanet:99361](http://www.orpha.net/ORDO/Orphanet_99361), [OMIM:155240](http://purl.obolibrary.org/obo/OMIM_155240), [OMIM:610755](http://purl.obolibrary.org/obo/OMIM_610755), [Orphanet:247709](http://www.orpha.net/ORDO/Orphanet_247709), [Orphanet:653](http://www.orpha.net/ORDO/Orphanet_653), [OMIM:131100](http://purl.obolibrary.org/obo/OMIM_131100), [Orphanet:276152](http://www.orpha.net/ORDO/Orphanet_276152), 

**Class expressions from DL-Learner:**

- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0200013](http://purl.obolibrary.org/obo/HP_0200013) (Neoplasm of fatty tissue) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0100733](http://purl.obolibrary.org/obo/HP_0100733) (Neoplasm of the parathyroid gland) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0100641](http://purl.obolibrary.org/obo/HP_0100641) (Neoplasm of the adrenal cortex) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0100633](http://purl.obolibrary.org/obo/HP_0100633) (Esophagitis) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0100631](http://purl.obolibrary.org/obo/HP_0100631) (Neoplasm of the adrenal gland) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0040277](http://purl.obolibrary.org/obo/HP_0040277) (Neoplasm of the pituitary gland) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0040077](http://purl.obolibrary.org/obo/HP_0040077) (Abnormal concentration of calcium in blood) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0030448](http://purl.obolibrary.org/obo/HP_0030448) (Soft tissue sarcoma) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0012733](http://purl.obolibrary.org/obo/HP_0012733) (Macule) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 66.67%
- [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) and [HP:0012316](http://purl.obolibrary.org/obo/HP_0012316) (Fibrous tissue neoplasm) 66.67%
- [HP:0012111](http://purl.obolibrary.org/obo/HP_0012111) (Abnormality of circulating glucocorticoid level) and [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) 66.67%
- [HP:0012031](http://purl.obolibrary.org/obo/HP_0012031) (Lipomatous tumor) and [HP:0012197](http://purl.obolibrary.org/obo/HP_0012197) (Insulinoma) 66.67%


